Pliant Therapeutics, Inc. (PLRX) delivered a return of -23.13% over the past year. Since PLRX does not currently pay dividends, the total return equals the price-only return.

A $10,000 investment in Pliant Therapeutics, Inc. one year ago would be worth $7,687 today, representing a loss of $2,313.

Pliant Therapeutics, Inc. (PLRX) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For PLRX, the total return equals the price-only return.

No, Pliant Therapeutics, Inc. (PLRX) underperformed the S&P 500 by 45.99 percentage points over the past year. PLRX delivered a total return of -23.13%, compared to the S&P 500's 22.86%. This means a passive S&P 500 index fund outperformed PLRX by 45.99pp during this period.

Pliant Therapeutics, Inc. (PLRX) experienced a maximum drawdown of -41.71% over the past year, declining from its peak on 2025-10-21 to its trough on 2026-02-05. The stock has not yet fully recovered to its prior peak. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.

Here are Pliant Therapeutics, Inc. (PLRX)'s long-term returns with dividends reinvested. Over 10 years, the total return is -94.7% (-25.4% CAGR) — $10,000 would have grown to $531. Over 20 years: -94.7% total return (-13.7% CAGR) — $10,000 → $531. Over 30 years: -94.7% total return (-9.3% CAGR) — $10,000 → $531. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.

Pliant Therapeutics, Inc.'s best calendar year was 2022 with a total return of 37.1%. Its worst year was 2025 with a total return of -90.8%. This range shows the volatility investors should expect — the difference between the best and worst year is 127.9 percentage points.